Jun 30, 2023 4:05pm EDT NeuBase Announces Closing of $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
Jun 29, 2023 8:30am EDT NeuBase Presents Non-Human Primate Data Illustrating Stealth Editors™ are Non-Immunogenic, Opening the Door to Redosing
Jun 28, 2023 2:17pm EDT NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
May 22, 2023 7:00am EDT NeuBase Announces Positive Preclinical Data Supporting the Capabilities of Stealth Editors™
May 11, 2023 4:15pm EDT NeuBase Reports Business Update and Financial Results for the First Quarter of 2023